Skip to main content
. 2006 Oct 18;2006(4):CD006198. doi: 10.1002/14651858.CD006198

Comparison 1. CS‐NANP vaccine versus control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 New malaria infection 3 307 Risk Ratio (M‐H, Fixed, 95% CI) 1.05 [0.82, 1.35]